Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation.


Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 23 10 2019
accepted: 28 04 2020
pubmed: 11 6 2020
medline: 14 7 2020
entrez: 11 6 2020
Statut: ppublish

Résumé

After allogeneic hematopoietic stem cell transplantation (HSCT), patients are repetitively vaccinated to reduce the risk of infection caused by the immune deficiency following allogeneic HSCT. By the vaccination of transplanted patients, the humoral memory function can be restored in the majority of cases. It is unknown, however, to what extent memory B cells derived from the donor contribute to the mobilization of antibody-secreting cells and long-term humoral memory in patients after allogeneic HSCT. We therefore analyzed patients after allogeneic HSCT for memory B cell responses 7 days after single vaccination against tetanus toxoid (TT), diphtheria toxoid (DT), pertussis toxoid (PT), Haemophilus influenzae type b (Hib), and poliovirus. Patients showed an insufficient mobilization of plasmablasts (PB) after vaccination, whereas healthy subjects (HD, n = 13) exhibited a significant increase of PB in the peripheral blood. Regarding vaccine-specific antibody-secreting PB, all HD responded against all vaccine antigens, as expected. However, only 65% of the patients responded with a measurable increase in IgG-secreting PB against TT, 65% against DT, 33% against PT, and 53% against poliovirus. Correspondingly, the antibody titers on day 7 after vaccination did not increase in patients. A significant increase of serum titers for the vaccine antigens was detectable in the majority of patients only after repetitive vaccinations. In contrast to the low mobilization of vaccine-specific PB after vaccination, a high number of PB before vaccination was detectable in patients following allogeneic HSCT. High frequencies of circulating PB correlated with the incidence of moderate/severe chronic GVHD. In summary, patients showed a weak mobilization of antigen-specific PB and an inadequate increase in antibody titers 7 days after the first vaccination. Patients with moderate or severe chronic GVHD in their history had a significantly higher percentage of IgG-secreting PB prior to vaccination. The antigen specificity of these IgG-secreting PB is currently unknown.

Identifiants

pubmed: 32519092
doi: 10.1007/s00277-020-04072-9
pii: 10.1007/s00277-020-04072-9
pmc: PMC7340644
doi:

Substances chimiques

13-valent pneumococcal vaccine 0
Antibodies, Bacterial 0
Antibodies, Viral 0
Diphtheria-Tetanus-Pertussis Vaccine 0
Haemophilus Vaccines 0
Immunoglobulin G 0
Pentavac 0
Pneumococcal Vaccines 0
Poliovirus Vaccine, Inactivated 0
Vaccines, Combined 0

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1895-1906

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB 643 und TRR 221

Références

J Clin Invest. 2017 Jun 30;127(7):2452-2463
pubmed: 28665299
Biol Blood Marrow Transplant. 2008 Feb;14(2):208-19
pubmed: 18215781
Blood. 2016 May 19;127(20):2427-38
pubmed: 26884374
Bone Marrow Transplant. 2015 Jul;50(7):978-83
pubmed: 25867652
Biol Blood Marrow Transplant. 2017 Jun;23(6):870-881
pubmed: 27751936
Blood. 2000 Nov 1;96(9):3290-3
pubmed: 11050018
Bone Marrow Transplant. 2005 Apr;35(8):737-46
pubmed: 15750612
Nat Rev Immunol. 2015 Mar;15(3):160-71
pubmed: 25698678
Blood. 2015 Mar 12;125(11):1703-7
pubmed: 25645355
Blood. 2005 Feb 15;105(4):1614-21
pubmed: 15507523
Blood. 2002 Dec 15;100(13):4358-66
pubmed: 12393425
Blood. 1990 Oct 15;76(8):1647-56
pubmed: 1698484
Biol Blood Marrow Transplant. 2017 Sep;23(9):1437-1446
pubmed: 28495643
Biol Blood Marrow Transplant. 2017 Oct;23(10):1614-1621
pubmed: 28624476
Sci Transl Med. 2015 Apr 1;7(281):281ra43
pubmed: 25834109
Eur J Haematol. 2015 Dec;95(6):514-23
pubmed: 25677646
Blood. 1994 Jul 15;84(2):657-63
pubmed: 8025290
Hematology Am Soc Hematol Educ Program. 2012;2012:265-70
pubmed: 23233590
Blood. 2015 Mar 12;125(11):1830-9
pubmed: 25605369
Exp Hematol. 2005 Apr;33(4):480-6
pubmed: 15781339
Blood. 1997 Jan 1;89(1):350-1
pubmed: 8978315
Transplantation. 2006 Dec 15;82(11):1387-95
pubmed: 17164703
J Immunol. 1979 Jun;122(6):2498-504
pubmed: 312871
Biol Blood Marrow Transplant. 2016 Jan;22(1):37-46
pubmed: 26363444
Bone Marrow Transplant. 2009 Oct;44(8):521-6
pubmed: 19861986
Bone Marrow Transplant. 1993 Oct;12(4):387-98
pubmed: 8275039
APMIS. 1996 May;104(5):383-8
pubmed: 8703445
Biol Blood Marrow Transplant. 2009 Jul;15(7):795-803
pubmed: 19539210
Virulence. 2016 Nov 16;7(8):901-916
pubmed: 27385018
Blood. 2001 Jun 1;97(11):3380-9
pubmed: 11369627
J Immunol. 2000 Nov 15;165(10):5970-9
pubmed: 11067960
Bone Marrow Transplant. 2003 Jul;32(1):65-72
pubmed: 12815480
Blood. 1992 Sep 1;80(5):1358-64
pubmed: 1325214

Auteurs

Julia Winkler (J)

Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Glückstrasse 6, 91054, Erlangen, Germany. julia.winkler@uk-erlangen.de.

Hannes Tittlbach (H)

Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Glückstrasse 6, 91054, Erlangen, Germany.
Department of Biology, Division of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Andrea Schneider (A)

Department of Biology, Division of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Corinna Buchstaller (C)

Department of Medical Informatics, Biometry, and Epidemiology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Andreas Mayr (A)

Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.

Ingrid Vasova (I)

Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Glückstrasse 6, 91054, Erlangen, Germany.

Wolf Roesler (W)

Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Glückstrasse 6, 91054, Erlangen, Germany.

Michael Mach (M)

Institute for Clinical and Molecular Virology, University Hospital Erlangen, Erlangen, Germany.

Andreas Mackensen (A)

Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Glückstrasse 6, 91054, Erlangen, Germany.

Thomas H Winkler (TH)

Department of Biology, Division of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH